Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1968 1
1969 1
1973 4
1974 1
1975 2
1977 4
1978 4
1979 8
1980 1
1981 1
1982 9
1983 7
1984 9
1985 3
1986 3
1987 8
1988 7
1989 15
1990 4
1991 3
1992 4
1993 4
1994 4
1995 15
1996 9
1997 15
1998 9
1999 13
2000 10
2001 24
2002 12
2003 11
2004 16
2005 16
2006 17
2007 19
2008 16
2009 10
2010 13
2011 9
2012 12
2013 14
2014 19
2015 12
2016 12
2017 11
2018 12
2019 19
2020 24
2021 29
2022 15
2023 22
2024 24

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

518 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
Makker V, Colombo N, Casado Herráez A, Santin AD, Colomba E, Miller DS, Fujiwara K, Pignata S, Baron-Hay S, Ray-Coquard I, Shapira-Frommer R, Ushijima K, Sakata J, Yonemori K, Kim YM, Guerra EM, Sanli UA, McCormack MM, Smith AD, Keefe S, Bird S, Dutta L, Orlowski RJ, Lorusso D; Study 309–KEYNOTE-775 Investigators. Makker V, et al. N Engl J Med. 2022 Feb 3;386(5):437-448. doi: 10.1056/NEJMoa2108330. Epub 2022 Jan 19. N Engl J Med. 2022. PMID: 35045221 Free PMC article. Clinical Trial.
Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.
Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, Gemma A, Harada M, Yoshizawa H, Kinoshita I, Fujita Y, Okinaga S, Hirano H, Yoshimori K, Harada T, Ogura T, Ando M, Miyazawa H, Tanaka T, Saijo Y, Hagiwara K, Morita S, Nukiwa T; North-East Japan Study Group. Maemondo M, et al. N Engl J Med. 2010 Jun 24;362(25):2380-8. doi: 10.1056/NEJMoa0909530. N Engl J Med. 2010. PMID: 20573926 Free article. Clinical Trial.
Effect of Taxane Plus Platinum Regimens vs Doxorubicin Plus Cisplatin as Adjuvant Chemotherapy for Endometrial Cancer at a High Risk of Progression: A Randomized Clinical Trial.
Nomura H, Aoki D, Michimae H, Mizuno M, Nakai H, Arai M, Sasagawa M, Ushijima K, Sugiyama T, Saito M, Tokunaga H, Matoda M, Nakanishi T, Watanabe Y, Takahashi F, Saito T, Yaegashi N; Japanese Gynecologic Oncology Group. Nomura H, et al. Among authors: tokunaga h. JAMA Oncol. 2019 Jun 1;5(6):833-840. doi: 10.1001/jamaoncol.2019.0001. JAMA Oncol. 2019. PMID: 30896757 Free PMC article. Clinical Trial.
Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.
Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, Kato T, Hara T, Hamaoka K, Ogawa S, Miura M, Nomura Y, Fuse S, Ichida F, Seki M, Fukazawa R, Ogawa C, Furuno K, Tokunaga H, Takatsuki S, Hara S, Morikawa A; RAISE study group investigators. Kobayashi T, et al. Among authors: tokunaga h. Lancet. 2012 Apr 28;379(9826):1613-20. doi: 10.1016/S0140-6736(11)61930-2. Epub 2012 Mar 8. Lancet. 2012. PMID: 22405251 Clinical Trial.
Unique Features of Halophilic Proteins.
Arakawa T, Yamaguchi R, Tokunaga H, Tokunaga M. Arakawa T, et al. Among authors: tokunaga h. Curr Protein Pept Sci. 2017;18(1):65-71. doi: 10.2174/1389203717666160617111140. Curr Protein Pept Sci. 2017. PMID: 27320124 Review.
Lymphadenectomy issues in endometrial cancer.
Konno Y, Asano H, Shikama A, Aoki D, Tanikawa M, Oki A, Horie K, Mitsuhashi A, Kikuchi A, Tokunaga H, Terao Y, Satoh T, Ushijima K, Ishikawa M, Yaegashi N, Watari H. Konno Y, et al. Among authors: tokunaga h. J Gynecol Oncol. 2021 Mar;32(2):e25. doi: 10.3802/jgo.2021.32.e25. Epub 2021 Jan 7. J Gynecol Oncol. 2021. PMID: 33470067 Free PMC article. Review.
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial.
Colombo N, Biagioli E, Harano K, Galli F, Hudson E, Antill Y, Choi CH, Rabaglio M, Marmé F, Marth C, Parma G, Fariñas-Madrid L, Nishio S, Allan K, Lee YC, Piovano E, Pardo B, Nakagawa S, McQueen J, Zamagni C, Manso L, Takehara K, Tasca G, Ferrero A, Tognon G, Lissoni AA, Petrella M, Laudani ME, Rulli E, Uggeri S, Barretina Ginesta MP; AtTEnd study group. Colombo N, et al. Lancet Oncol. 2024 Sep;25(9):1135-1146. doi: 10.1016/S1470-2045(24)00334-6. Epub 2024 Aug 2. Lancet Oncol. 2024. PMID: 39102832 Clinical Trial.
Steroidogenic factor-1 and endometriosis.
Bulun SE, Utsunomiya H, Lin Z, Yin P, Cheng YH, Pavone ME, Tokunaga H, Trukhacheva E, Attar E, Gurates B, Milad MP, Confino E, Su E, Reierstad S, Xue Q. Bulun SE, et al. Among authors: tokunaga h. Mol Cell Endocrinol. 2009 Mar 5;300(1-2):104-8. doi: 10.1016/j.mce.2008.12.012. Epub 2008 Dec 25. Mol Cell Endocrinol. 2009. PMID: 19150483 Review.
Role of estrogen receptor-β in endometriosis.
Bulun SE, Monsavais D, Pavone ME, Dyson M, Xue Q, Attar E, Tokunaga H, Su EJ. Bulun SE, et al. Among authors: tokunaga h. Semin Reprod Med. 2012 Jan;30(1):39-45. doi: 10.1055/s-0031-1299596. Epub 2012 Jan 23. Semin Reprod Med. 2012. PMID: 22271293 Free PMC article. Review.
Diagnostic Performance of Preoperative Imaging in Endometrial Cancer.
Hashimoto C, Shigeta S, Shimada M, Shibuya Y, Ishibashi M, Kageyama S, Sato T, Tokunaga H, Takase K, Yaegashi N. Hashimoto C, et al. Among authors: tokunaga h. Curr Oncol. 2023 Sep 6;30(9):8233-8244. doi: 10.3390/curroncol30090597. Curr Oncol. 2023. PMID: 37754512 Free PMC article.
518 results